PRESS RELEASES More events are coming soon. Keyword Search Year: 2022202120202019201820172016201520142013 06/29/21 Summary Toggle TRACON Pharmaceuticals Announces Orphan Drug Designation for Envafolimab in Soft Tissue Sarcoma Printer Friendly PDF Version 06/04/21 Summary Toggle TRACON Pharmaceuticals Presents Data from a Phase 1 Study of Uliledlimab (TJ004309) and Tecentriq® (Atezolizumab) at the American Society of Clinical Oncology Virtual Annual Meeting Printer Friendly PDF Version 06/01/21 Summary Toggle TRACON Pharmaceuticals Announces Results of Independent Data Monitoring Committee Review of Safety Data from ENVASARC Pivotal Trial Printer Friendly PDF Version 05/25/21 Summary Toggle TRACON Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference Printer Friendly PDF Version 05/20/21 Summary Toggle TRACON Pharmaceuticals Announces Poster Presentations at the 2021 ASCO Virtual Annual Meeting Printer Friendly PDF Version 05/05/21 Summary Toggle TRACON Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update Printer Friendly PDF Version 05/03/21 Summary Toggle TRACON Pharmaceuticals Announces Appointment of Dongliang Zhuang, Ph.D. as Vice President of Statistics and Biometrics Printer Friendly PDF Version 04/28/21 Summary Toggle TRACON to Report First Quarter 2021 Financial Results and Company Highlights on May 5, 2021 Printer Friendly PDF Version 03/23/21 Summary Toggle TRACON Pharmaceuticals Announces Poster Presentation at the 2021 AACR Virtual Annual Meeting Printer Friendly PDF Version 03/09/21 Summary Toggle TRACON Pharmaceuticals to Present at the Oppenheimer 31st Annual Healthcare Conference Printer Friendly PDF Version Pagination First page First Previous page Previous … Page 3 Current page 4 Page 5 Page 6 … Next page Next Last page Last
